MedCap AB (publ) OMXSTO:MCAP:
HAS SIGNED AN AGREEMENT TO ACQUIRE BIOPSAFE APS IN DENMARK
ACQUISITION AT CASH PURCHASE PRICE OF 115 MDKK ADJUSTED FOR CASH AND NET DEBT AT CLOSING ON JUNE 26
MedCap Signs Agreement To Acquire Biopsafe In Denmark
Earlier from MedCap
- MedCap Completes Buyback Program
- MCAP: Q1 2026 delivered double-digit revenue and profit growth, driven by strong segment performance
- MedCap (Q4 review): Beat on Solid Organic Growth
- MCAP: Record sales and EBITA growth in 2025, supported by strong operations and acquisitions
- MCAP: Life science group achieves robust growth via acquisitions and innovation in core business areas
Follow MedCap into a list and get an email when it puts out news.
Follow MedCap